The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 11,001–11,100 of 31,469
Evaluation of neuroendocrine status in longevity
Baranowska, B., Wolińska‐Witort, E., Bik, W., Baranowska-Bik, A., Martyńska, L., & Chmielowska, M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.014 · Cited by 32
Bradley, S. J., Kingwell, B. A., Canny, B. J., & McConell, G. K. (2007) · Metabolism · doi:10.1016/j.metabol.2007.06.003 · Cited by 32
de Ferran, K., Paiva, I. A., Garcia, L. D. S., Gama, M. D. P., & Guimarães, M. M. (2011) · Hormone Research in Paediatrics · doi:10.1159/000324107 · Cited by 32
Florêncio, T. T., Ferreira, H. S., Cavalcante, J. C., Veiga, G. R. S., & Sawaya, A. L. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328010f24d · Cited by 32
Moriyama, K., Negami, M., & Takahashi, E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.08.007 · Cited by 32
Retinol-binding protein 4 and insulin resistance in preeclampsia
Masuyama, H., Inoue, S., & Hiramatsu, Y. (2010) · Endocrine Journal · doi:10.1507/endocrj.k10e-288 · Cited by 32
ABO Genotype, ‘Blood-Type’ Diet and Cardiometabolic Risk Factors
Wang, J., García‐Bailo, B., Nielsen, D. E., & El‐Sohemy, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084749 · Cited by 36
Impact of Acute and Chronic Low-Dose Glucocorticoids on Protein Metabolism
Burt, M. G., Johannsson, G., Umpleby, A. M., Chisholm, D. J., & Ho, K. K. Y. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0951 · Cited by 31
Fornage, M., Jacobs, D. R., Steffes, M. W., et al. (2005) · Metabolism · doi:10.1016/j.metabol.2005.02.005 · Cited by 32
Pericardial fat, insulin resistance, and left ventricular structure and function in morbid obesity
Pucci, G., Battista, F., VUONO, S. D., Boni, M., Scavizzi, M., Ricci, M. A., Lupattelli, G., & Schillaci, G. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.09.016 · Cited by 32
Metabolomics reveals determinants of weight loss during lifestyle intervention in obese children
Wahl, S., Holzapfel, C., Yu, Z., Breier, M., Kondofersky, I., Fuchs, C., Singmann, P., Prehn, C. P., Adamski, J., Grallert, H., et al. (2013) · Metabolomics · doi:10.1007/s11306-013-0550-9 · Cited by 32
Ibrahim, M. A., Amin, E. F., Ibrahim, S. A., Abdelzaher, W. Y., & Abdelrahman, A. M. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.12.024 · Cited by 32
The effects of sex, metabolic syndrome and exercise on postprandial lipemia
Cox‐York, K. A., Sharp, T. A., STOTZ, S. A., Bessesen, D. H., Pagliassotti, M. J., & Horton, T. J. (2012) · Metabolism · doi:10.1016/j.metabol.2012.08.003 · Cited by 34
Tomé, M. A., Botana, M., Cadarso-Suárez, C., Iraeta, A. R., Fernández-Mariño, A., Mato, J. A. M., Solache, I., & Pérez-Fernández, R. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346497 · Cited by 32
Genetic Variance in the Adiponutrin Gene Family and Childhood Obesity
Johansson, L. E., Johansson, L., Danielsson, P., Norgren, S., Johansson, S. M., Marcus, C., & Ridderstråle, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005327 · Cited by 32
β-Cell Function and Insulin Resistance in Pregnancy and Their Relation to Fetal Development
Das, S., Behera, M. K., Misra, S., & Baliarsihna, A. K. (2009) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0017 · Cited by 31
Screening of Metabolic Syndrome in Obese Children: A Primary Care Concern
Viggiano, D., FILIPPO, G. D., Rendina, D., Fasolino, A., D'Alessio, N., Avellino, N., Verga, M. C., Prisco, A. G., Sorrentino, F., Sabatini, P., et al. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31819b54b7 · Cited by 30
Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus
Haymana, C., Sonmez, A., Tapan, S., Safer, U., Celebi, G., Ozturk, O., Genç, H., Doğru, T., Tasci, I., Erdem, G., et al. (2010) · Endocrine · doi:10.1007/s12020-010-9334-4 · Cited by 33
Serum concentrations of vitamins A and E in impaired glucose tolerance
Tavridou, A., Unwin, N. C., Laker, M. F., White, M. J., & Alberti, K. G. M. M. (1997) · Clinica Chimica Acta · doi:10.1016/s0009-8981(97)00123-x · Cited by 32
Polycystic ovary syndrome and chronic autoimmune thyroiditis
Mayrink, J., Benetti‐Pinto, C. L., Garmes, H. M., Jales, R. M., & Juliato, C. R. T. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.958990 · Cited by 34
Gustavsson, S., Fagerberg, B., Sällsten, G., & Andersson, E. M. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph110403521 · Cited by 33
Teixeira, P. D. F. D. S., Cabral, M. D., Silva, N. A., Soares, D. V., Bráulio, V. B., Couto, A. P. C. B., Henriques, J. L. M., Costa, A. J. L., Buescu, A., & Vaisman, M. (2009) · Thyroid · doi:10.1089/thy.2007.0393 · Cited by 32
Rubio-Ruiz, M. E., del Valle‐Mondragón, L., Castrejón-Téllez, V., Carreón‐Torres, E., Díaz‐Díaz, E., & Guarner‐Lans, V. (2014) · Peptides · doi:10.1016/j.peptides.2014.04.021 · Cited by 32
Zhang, H., Chen, L. L., Wang, L., Liao, Y.-F., Wu, Z., Ye, F., Xu, S., & Yi, L. L. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346463 · Cited by 32
Huang, L.-H., Liao, Y.-L., & Hsu, C.-H. (2011) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2011.11.003 · Cited by 32
Khanal, R. C., Rogers, T. J., Wilkes, S. E., Howard, L. R., & Prior, R. L. (2010) · Food & Function · doi:10.1039/c0fo00089b · Cited by 32
Role of the Oral Glucose Tolerance Test (OGTT) in the idiopathic restless legs syndrome
Bosco, D., Plastino, M., Fava, A., Ettore, M., Bosco, F., Ermio, C., Tallarigo, F., Pirritano, D., & Consoli, D. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.09.008 · Cited by 32
Sancaklı, Ö., Darendelıler, F., Baş, F., Gokcay, G., Dişçi, R., Akı, S., & Eskiyurt, N. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03138.x · Cited by 32
The 2005 Dietary Guidelines for Americans and Insulin Resistance in the Framingham Offspring Cohort
Fogli-Cawley, J. J., Dwyer, J. T., Saltzman, E. J., McCullough, M. L., Troy, L. M., Meigs, J. B., & Jacques, P. F. (2007) · Diabetes Care · doi:10.2337/dc06-1927 · Cited by 32
Rašić-Milutinović, Z., Peruničić, G., Plješa, S., Gluvic, Z. M., Ilić, M., & Stokić, E. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.0092 · Cited by 32
Composition of lower extremity in relation to a high ankle–brachial index
Tabara, Y., Igase, M., Kido, T., Ochi, N., Miki, T., & Kohara, K. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328314b821 · Cited by 32
Mukai, Y., Kumazawa, M., & Sato, S. (2012) · Endocrine · doi:10.1007/s12020-012-9815-8 · Cited by 33
Olmedillas, H., Sanchis‐Moysi, J., Fuentes, T., Guadalupe‐Grau, A., Ponce‐González, J. G., Morales‐Álamo, D., Santana, A., Dorado, C., Calbet, J. A. L., & Guerra, B. (2009) · European Journal of Applied Physiology · doi:10.1007/s00421-009-1281-5 · Cited by 32
Increasing maternal parity predicts neonatal adiposity: Pune Maternal Nutrition Study
Joshi, N. P., Kulkarni, S. R., Yajnik, C. S., et al. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.01.020 · Cited by 32
Negro, R., & Hassan, H. (2006) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2006.045 · Cited by 32
Akarte, A. S., Srinivasan, B. P., & Gandhi, S. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.10.003 · Cited by 32
Rashad, N. M., El‐Shal, A. S., & Abdelaziz, A. M. (2012) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2012.10.007 · Cited by 32
Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation
Eguchi, Y., Mizuta, T., Ishibashi, E., Kitajima, Y., Oza, N., Nakashita, S., Hara, M., Iwane, S., Takahashi, K., Akiyama, T., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01853.x · Cited by 32
Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients
Merchante, N., Rivero, A., Santos, I. D. L., Merino, D., Márquez, M., López‐Ruz, M. Á., Rodríguez‐Baño, J., del Valle, J., Camacho, Á., Sanz-Sanz, J., et al. (2009) · Gut · doi:10.1136/gut.2009.179085 · Cited by 33
Polychlorinated Biphenyl Exposure and Glucose Metabolism in 9-Year-Old Danish Children
Jensen, T. K., Timmermann, C. A. G., Rossing, L. I., Ried‐Larsen, M., Grøntved, A., Andersen, L. B., Dalgård, C., Hansen, O. H., Scheike, T., Nielsen, F., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1683 · Cited by 32
Leikin-Frenkel, A. I., Goldiner, I., Leikin-Gobbi, D., Rosenberg, R. A., Bonen, H., Litvak, A., Bernheim, J., Konikoff, F. M., & Gilat, T. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282fc9743 · Cited by 32
ORTEGA, J. F., Hamouti, N., Fernández-Elías, V. E., de Prada, V. G., Martínez‐Vizcaíno, V., & Mora‐Rodríguez, R. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0580-4 · Cited by 33
Prevalence of GCK mutations in individuals screened for fasting hyperglycaemia
Gloyn, A. L., van de Bunt, M., STRATTON, I. M., Lonie, L. J., Tucker, L., Ellard, S., & Holman, R. R. (2008) · Diabetologia · doi:10.1007/s00125-008-1188-4 · Cited by 32
Komorowski, J. R., Tuzcu, M., Şahin, N., Juturu, V., Orhan, C., Ulaş, M., & Şahin, K. (2012) · Biological Trace Element Research · doi:10.1007/s12011-012-9393-x · Cited by 32
Reduced Circulating Androgen Levels After Gastric Bypass Surgery in Severely Obese Women
Ernst, B., Wilms, B., Thurnheer, M., & Schultes, B. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0823-9 · Cited by 32
Relative fat-free mass deficiency and left ventricular adaptation to obesity: The Strong Heart Study
SIMONE, G. D., Pasanisi, F., Ferrara, A. L., Roman, M. J., Lee, E. T., Contaldo, F., Howard, B. V., & Devereux, R. B. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.09.055 · Cited by 32
Sommer, G., Ziegelmeier, M., Bachmann, A., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03277.x · Cited by 32
Kawamoto, R., Tabara, Y., Kohara, K., Miki, T., Ohtsuka, N., Kusunoki, T., & Abe, M. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.3681 · Cited by 32
Advanced oxidation protein products in obese women: its relation to insulin resistance and resistin
Koçak, H., Öner-İyidoğan, Y., Gürdöl, F., Öner, P., Suzme, R., Esin, D., & İşsever, H. (2007) · Clinical and Experimental Medicine · doi:10.1007/s10238-007-0143-x · Cited by 32
Brouwer, B. G., Visseren, F. L. J., & van der Graaf, Y. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.07.031 · Cited by 30
Prehypertension is associated with insulin resistance
Hwu, C., Liou, T., Hsiao, L.-C., & Lin, M. (2009) · QJM · doi:10.1093/qjmed/hcp107 · Cited by 32
Plasma apolipoprotein M is reduced in metabolic syndrome but does not predict intima media thickness
Dullaart, R. P. F., Plomgaard, P., de Vries, R., Dahlbäck, B., & Nielsen, L. B. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.06.010 · Cited by 32
Cutaneous Blood Flow in Type 2 Diabetic Individuals After an Acute Bout of Maximal Exercise
Colberg, S. R., Parson, H. K., Holton, D. R., Nunnold, T., & Vinik, A. I. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1883 · Cited by 32
Impact of Common Variation in Bone-Related Genes on Type 2 Diabetes and Related Traits
Billings, L. K., Hsu, Y., Ackerman, R. J., Dupuis, J., Voight, B. F., Rasmussen‐Torvik, L. J., Herçberg, S., Lathrop, M. G., Barnes, D. R., Langenberg, C., et al. (2012) · Diabetes · doi:10.2337/db11-1515 · Cited by 34
Association between thyroid hormones, insulin resistance, and metabolic syndrome
Kumar, K. V. S. H., Yadav, R. K., Prajapati, J., et al. (2009) · Saudi Medical Journal · doi:10.15537/1658-3175.4771 · Cited by 32
Alisi, A., Nobili, V., Ceccarelli, S., Panera, N., Stefanis, C. D., Vito, R. D., Vitali, R., Bedogni, G., Balsano, C., Cucchiara, S., et al. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.928205 · Cited by 36
Ooi, E. M. M., Ng, T. W. K., Chan, D. C., & Watts, G. F. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.06.003 · Cited by 35
McCallum, R. W., Parameswaran, V., & Burgess, J. R. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02563.x · Cited by 32
Möhlig, M., Weickert, M. O., Ghadamgahi, E., Arafat, A. M., Spranger, J., Pfeiffer, A. F. H., & Schöfl, C. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0833 · Cited by 32
Low vitamin D concentrations among indigenous Argentinean children living at high altitudes
Hirschler, V., Maccallini, G., Molinari, C., Aranda, C., & on behalf of San Antonio de los Cobres Study Group (2012) · Pediatric Diabetes · doi:10.1111/pedi.12004 · Cited by 33
Heden, T. D., Liu, Y., Park, Y.-M., Nyhoff, L. M., Winn, N. C., & Kanaley, J. A. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.081232 · Cited by 34
Brasileiro, R. S., Escrivão, M. A. M. S., Taddei, J. A. D. A. C., D’Almeida, V., Ancona-Lopez, F., & Carvalhaes, J. T. A. (2005) · PubMed · Cited by 32
Lifestyle intervention in non-alcoholic fatty liver disease in Chengyang District, Qingdao, China
Sun, W. (2012) · World Journal of Hepatology · doi:10.4254/wjh.v4.i7.224 · Cited by 32
Pfützner, A., Standl, E., Strotmann, H.-J., Schulze, J., Hohberg, C., Lübben, G., Pahler, S., Schöndorf, T., & Forst, T. M. (2006) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2006.108 · Cited by 33
Infliximab and insulin resistance
Ursini, F., Naty, S., & Grembiale, R. D. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.12.014 · Cited by 31
The changes in serum leptin, body fat mass and insulin resistance after renal transplantation
Kayacan, S. M., Yıldız, A., Kazancıoğlu, R., Şahin, S., Sever, M. Ş., & Ark, E. (2003) · Clinical Transplantation · doi:10.1034/j.1399-0012.2003.02078.x · Cited by 32
van Vliet, M., von Rosenstiel, I. A., Schindhelm, R. K., et al. (2008) · European Journal of Pediatrics · doi:10.1007/s00431-008-0802-2 · Cited by 32
Wang, C., Yatsuya, H., Tamakoshi, K., Uemura, M. Y., Li, Y., Wada, K., Yamashita, K., Kawaguchi, L., Toyoshima, H., & Aoyama, A. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2406 · Cited by 32
Asensi, V., Roces, E., Carton, J. A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/421774 · Cited by 32
Veilleux, A., Mayeur, S., Bérubé, J., Beaulieu, J., Tremblay, É., Hould, F., Bossé, Y., Richard, D., & Levy, E. H. (2015) · BMC Gastroenterology · doi:10.1186/s12876-015-0342-y · Cited by 32
Losartan and Pioglitazone Ameliorate Nephropathy in Experimental Metabolic Syndrome Rats
Kong, X., Zhang, D.-Y., Wu, H., et al. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.693 · Cited by 32
Brar, P., Mengwall, L., Franklin, B., & Fierman, A. (2014) · La Clinica pediatrica · doi:10.1177/0009922814528571 · Cited by 33
Early cardiovascular changes occurring in diet-induced, obese insulin-resistant rats
Huisamen, B., Dietrich, D., Bezuidenhout, N., Lopes, J., Flepisi, B. T., Blackhurst, D., & Lochner, A. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1340-9 · Cited by 32
Jiménez‐Pavón, D., Castillo, M. J., Moreno, L. A., Kafatos, A., Μanios, Y., Kondaki, K., Béghin, L., Zaccaria, M., Henauw, S. D., Widhalm, K., et al. (2011) · International Journal of Pediatric Obesity · doi:10.3109/17477166.2011.575158 · Cited by 35
Insulin Resistance and C-reactive Protein in Preeclampsia
Stefanović, M., Vukomanović, P., Milosavljević, M., Kutlesic, R. M., Popović, J., & Tubić-Pavlović, A. (2009) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2009.2813 · Cited by 32
Rees, E., Coulson, R.-M. K., Dunstan, F., Evans, W. D., Blundell, H. L., Luzio, S. D., Dunseath, G. J., Halcox, J., Fraser, A. G., & Rees, A. (2014) · Human Reproduction · doi:10.1093/humrep/deu180 · Cited by 32
Valsamakis, G., Margeli, A., Vitoratos, N., Boutsiadis, A., Sakkas, E. G., Papadimitriou, G. N., Al‐Daghri, N. M., Botsis, D. S., Kumar, S., Papassotiriou, I., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0047 · Cited by 33
Insulin activation of plasma non-esterified fatty acid uptake in metabolic syndrome
Ramos-Roman, M., Lapidot, S. A., Phair, R., & Parks, E. (2012) · Arteriosclerosis, Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.250019 · Cited by 30
Örnek, Z., Demirel, F., Dursun, A., Ermiş, B., Pişkin, E., & Bıdecı, A. (2012) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2012.1583 · Cited by 32
Sharma, N., Sajuthi, S. P., Chou, J. W., Calles-Escandón, J., Demons, J. L., Rogers, S. D., Ma, L., Palmer, N. D., McWilliams, D. R., Beal, J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3336 · Cited by 34
Nonlinear Relationship between Birth Weight and Visceral Fat in Adolescents
Stansfield, B. K., Fain, M. E., Bhatia, J. J. S., Gutin, B., Nguyen, J., & Pollock, N. K. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.04.012 · Cited by 32
Chang, Y., Jung, H. S., Yun, K. E., Cho, J., Ahn, J., Chung, E. C., Shin, H. C., & Ryu, S. (2016) · Obesity · doi:10.1002/oby.21580 · Cited by 32
Afarideh, M., Aryan, Z., Ghajar, A., Noshad, S., Nakhjavani, M., Baber, U., Mechanick, J. I., & Esteghamati, A. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.09.009 · Cited by 32
Serotonin Transporter Binding in the Diencephalon Is Reduced in Insulin-Resistant Obese Humans
Versteeg, R. I., Koopman, K. E., Booij, J., Ackermans, M. T., Unmehopa, U. A., Fliers, E., la Fleur, S. E., & Serlie, M. J. M. (2016) · Neuroendocrinology · doi:10.1159/000450549 · Cited by 32
Ilinčić, B., Stokić, E., Stosić, Z., Kojić, N. E., Katsiki, N., Mikhailidis, D. P., & Isenović, E. R. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.61812 · Cited by 32
Afifi, N. A., Ramadan, A., Erian, E. Y., Saleh, D. O., Sedik, A. A., Badawi, M., & hotaby, W. E. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0269 · Cited by 32
Glucose tolerance and insulin responsiveness in Gitelman syndrome patients
Yuan, T., Jiang, L., Chen, C., Peng, X., Nie, M., Li, X., Xing, X., Li, X., & Chen, L. (2017) · Endocrine Connections · doi:10.1530/ec-17-0014 · Cited by 32
Is the FVB/N mouse strain truly resistant to diet-induced obesity?
Nascimento-Sales, M., Fredo-da-Costa, I., Mendes, A. C. B., Melo, S. D. S., Ravache, T. T., Gomez, T. G. B., Gaisler-Silva, F., Ribeiro, M. O., Santos, A. R., Carneiro‐Ramos, M. S., et al. (2017) · Physiological Reports · doi:10.14814/phy2.13271 · Cited by 35
Saha, S., & Schwarz, P. E. H. (2017) · Journal of Public Health · doi:10.1007/s10389-017-0805-4 · Cited by 33
True, C. A., Takahashi, D. L., Burns, S. E., Mishler, E., Bond, K., Wilcox, M. C., Calhoun, A. R., Bader, L., Dean, T. A., Ryan, N. D., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dex246 · Cited by 32
Predictors of Insulin Resistance in Children versus Adolescents with Obesity
Lentferink, Y. E., Elst, M. A. J., Knibbe, C. A. J., & van der Vorst, M. M. J. (2017) · Journal of Obesity · doi:10.1155/2017/3793868 · Cited by 34
Marzuillo, P., Grandone, A., Sessa, A. D., Guarino, S., Diplomatico, M., Umano, G. R., Polito, C., Manna, A. L., Perrone, L., & del Giudice, E. M. (2018) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2018.01.001 · Cited by 33
Filgueiras, M. D. S., Suhett, L. G., Silva, M. A., Rocha, N. P., & de Novaes, J. F. (2018) · Public Health Nutrition · doi:10.1017/s1368980018000204 · Cited by 32
Are there any new reliable markers to detect renal injury in obese children?
Gayret, Ö. B., Taşdemir, M. S., Erol, M., Nacaroğlu, H. T., Zengi, O., & Yiğit, Ö. (2018) · Renal Failure · doi:10.1080/0886022x.2018.1489284 · Cited by 33
Toshimitsu, T., Gotou, A., Furuichi, K., Hachimura, S., & Asami, Y. (2018) · Nutrition · doi:10.1016/j.nut.2018.07.116 · Cited by 33
Zayed, E. A., Ain-Shoka, A. A., El-Shazly, K. A., & Latif, H. A. A. E. (2018) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22218 · Cited by 32
Tupikowska, M., Kolačkov, K., Zdrojowy-Wełna, A., et al. (2019) · BioMed Research International · doi:10.1155/2019/7304345 · Cited by 32
Arase, Y., Shiraishi, K., Anzai, K., Sato, H., Teramura, E., Tsuruya, K., Hirose, S., Deguchi, R., Toyoda, M., Mine, T., et al. (2019) · Clinical Drug Investigation · doi:10.1007/s40261-019-00785-6 · Cited by 32
Altered clot kinetics in patients with non-alcoholic fatty liver disease
Hickman, I. J., Sullivan, C. M., Flight, S., et al. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31746-6 · Cited by 32
Cryptogenic cirrhosis in the region where obesity is not prevalent
Kojima, H. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i13.2080 · Cited by 32
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
